 |
|
altretamine
A synthetic cytotoxic s-triazine derivative similar in structure to alkylating agent triethylenemelamin with antineoplastic activity. Although the precise mechanism by which altretamine exerts its cytotoxic effect is unknown, N-demethylation of altretamine may produce reactive intermediates which covalently bind to DNA, resulting in DNA damage. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | Hemel
Hexaloids | | | | US brand names: | | Hexalen
hexamethylmelamine | | | | Foreign brand names: | | Hexastat
Hexinawas | | | | Abbreviations: | | HMM
HXM | | | | Code names: | | ENT-50852
RB-1515
WR-95704 | | | | Chemical structure names: | | - 2,4,6-tris(dimethylamino)-s-triazine
- N,N,N',N',N",N"-hexamethyl-1,3,5-triazine-2,4,6-triamine
| | |
| Previous: | alpha-1,3-galactosyltransferase-expressing allogeneic lung tumor cell vaccine, alpha-1,3-galactosyltransferase-expressing allogeneic pancreatic tumor cell vaccine, alprazolam, alprostadil, Althose | | Next: | alum adjuvant, ALVAC(2) melanoma multi-antigen therapeutic vaccine, ALVAC-hB7.1, alvimopan, alvocidib |
|
|
